Ernexa Therapeutics Analyst Price Targets

Ernexa Therapeutics Inc

ERNANASDAQ

$1.99

0.03311.69%

Ult. Agg.: Oct 27, 8:22 AM

Ernexa Therapeutics Analyst Price Targets - Benzinga

Wall Street analyst price targets and consensus rating for Ernexa Therapeutics (ERNA).

Price Target Range — 1 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingBuy# Analysts1Avg. Consensus PT$30Upside to Avg. PT+1295.3%

Rating Trend — Last 9 Months

Date	Firm	Analyst	Action	Rating Change	Price Target
May 7, 2026	Brookline Capital	—	Initiate	Buy	$30

Benzinga Newsdesk